Abilify is found to be the preferred brand for the treatment of Schizophrenia according to surveyed U.S. Psychiatrists and Payers
via Marketing - United States - Latest News http://ift.tt/1tIOLvz
via Marketing - United States - Latest News http://ift.tt/1tIOLvz
Keine Kommentare:
Kommentar veröffentlichen